Lisata Therapeutics, Inc. (LSTA)

CIK 320017 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lisata Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 19, 2026DEF 14A0001140361-26-039986
Oct 19, 2026ARS0001140361-26-040000
Oct 15, 202630001140361-26-039795
Oct 14, 20268-K0001140361-26-039602
Oct 7, 2026PRE 14A0001140361-26-038937
Oct 2, 2026D0000320017-26-000039
Sep 28, 202630001140361-26-037878
Sep 28, 202630001140361-26-037879
Sep 17, 20268-K0001140361-26-036866
Aug 26, 2026SCHEDULE 13G0002150037-26-000001
Aug 6, 202610-Q0000320017-26-000038
Aug 4, 20268-K0001140361-26-031028
Jul 28, 2026SC TO-T/A0001140361-26-029893
Jul 24, 20268-K0001140361-26-029541
Jul 21, 2026SC 14D9/A0001140361-26-029022
Jul 17, 2026SC TO-T/A0001140361-26-028733
Jul 17, 20268-K0001140361-26-028763
Jul 17, 2026SC 14D9/A0001140361-26-028761
Jul 13, 2026SC 14D9/A0001140361-26-028257
Jul 10, 2026SC TO-T/A0001140361-26-028238
Jul 2, 2026SC 14D9/A0001140361-26-027435
Jun 10, 2026SC TO-T0001140361-26-024731
Jun 10, 2026SC 14D90001140361-26-024737
Jun 9, 2026SC14D9C0001140361-26-024561
Jun 9, 20268-K0001140361-26-024560